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Foot orthoses for adults with flexible pes planus:
a systematic review
Helen A Banwell1*, Shylie Mackintosh1,3 and Dominic Thewlis2,3
Abstract
Background: Foot orthoses are widely used in the management of flexible pes planus, yet the evidence to support
this intervention has not been clearly defined. This systematic review aimed to critically appraise the evidence for
the use of foot orthoses for flexible pes planus in adults.
Methods: Electronic databases (Medline, CINAHL, Cochrane, Web of science, SportDiscus, Embase) were
systematically searched in June 2013 for randomised controlled, controlled clinical and repeated measure trials
where participants had identified flexible pes planus using a validated and reliable measure of pes planus and the
intervention was a rigid or semi-rigid orthoses with the comparison being a no-orthoses (shoes alone or flat
non-posted insert) condition. Outcomes of interest were foot pain, rearfoot kinematics, foot kinetics and
physical function.
Results: Of the 2,211 articles identified by the searches, 13 studies met the inclusion criteria; two were randomised
controlled trials, one was a controlled trial and 10 were repeated measure studies. Across the included studies, 59
relevant outcome measures were reported with 17 calculated as statistically significant large or medium effects
observed with use of foot orthoses compared to the no orthoses condition (SMD range 1.13 to −4.11).
Conclusions: No high level evidence supported the use of foot orthoses for flexible pes planus. There is good to
moderate level evidence that foot orthoses improve physical function (medial-lateral sway in standing (level II) and
energy cost during walking (level III)). There is low level evidence (level IV) that foot orthoses improve pain, reduce
rearfoot eversion, alter loading and impact forces; and reduce rearfoot inversion and eversion moments in flexible
pes planus. Well-designed randomised controlled trials that include appropriate sample sizes, clinical cohorts and
involve a measure of symptom change are required to determine the efficacy of foot orthoses to manage adult
flexible pes planus.
Keywords: Pes planus, Flat feet, Orthoses, Foot, Shoe inserts, Orthotic, Kinematics, Kinetics
Background
Pes planus (flat foot) is an umbrella term to describe feet
with a visually lowered medial longitudinal arch often in
association with rearfoot eversion [1,2]. Pes planus pre-
sents in two forms, described as rigid or flexible [3]. The
World Health Organisation defines rigid pes planus as a
congenital, rigid or spastic deformity of the foot and
flexible pes planus as an acquired joint disorder resulting
in a valgus foot deformity [4]. Rigid pes planus affects
less than 1% of the population and leads to significant
pain and disability often requiring surgical intervention
[5,6]. Flexible pes planus reportedly affects between 2 to
23% of the U.S. adult population [1,7-9] with prognoses
and intervention pathways remaining predominantly un-
clear, undefined and controversial [2,10,11]. Although
well recognised within clinical practice and orthopaedic
literature, no universally accepted classification and stan-
dardised measure of flexible pes planus exists [12-14].
Radiographic investigations are the reference standard to
determine magnitude of pes planus; however, it is mea-
sured clinically using a variety of static foot posture indi-
ces, each with their own limitations [12,13,15].
Painful symptomatic presentations associated with flexible
pes planus include: generalised lower limb pain; increased
lower limb fatigue, Achilles tendinopathy, osteoarthritis,
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patellofemoral disorders and hip pain [1,16,17]. No
agreement exists on the aetiology of flexible pes planus;
however, frequently reported signs include abnormal
rearfoot kinematics (e.g. excessive rearfoot eversion or in-
creased range of rearfoot eversion), abnormal foot and
ankle kinetics (e.g. elevated joint moments or abnormal
loading forces) and altered physical function (e.g. altered
muscle activation and timing or increased energy con-
sumption) [18-21]. The symptoms of flexible pes planus
have been attributed to the functional consequences of
these signs [22] and intervention should be aimed at ad-
dressing these abnormalities [23].
Foot orthoses (FOs) are frequently prescribed inter-
ventions for flexible pes planus [24-26]. The most com-
monly prescribed FOs in Australia, the ‘modified Root
device’ [27], were originally developed to influence the
position of the subtalar joint towards a neutral position
and reduce abnormal motion around this joint [28-30].
Subsequent views on the reported mechanism of how
FOs affect the foot has evolved and, while variations
exist, Kirby’s definition of “an in-shoe medical device
that alters magnitudes and temporal patterns of the re-
action forces… and thus allowing for a more normal foot
and lower extremity function that decreases pathological
loading forces” is often cited [31]. Therefore, based on
these definitions, the use of FOs to alter the signs of
flexible pes planus and ameliorate symptoms is plausible.
The question is; does research evidence exist to support
this notion? To our knowledge a systematic review in-
vestigating the use of FOs for a targeted adult flexible
pes planus population has not been undertaken. With a
limited understanding on how FOs impact on the signs
and symptoms associated with flexible pes planus, there
remains some controversy as to when and how clinicians
determine if FOs are required [10,32-34]. Therefore, the
aim of this systematic review was to assess the effective-
ness of FOs to reduce foot pain, alter rearfoot kinematics
and kinetics and improve physical function for adults
with flexible pes planus.
Methods
Search strategy
The following databases were searched from inception to
June 2013: Ovid Medline® (from January 1966 to date);
CINAHL (from 1982 to date); Cochrane Central Register
of Controlled Trials (CENTRAL) (issue 5, May 2013); Web
of Science (from inception to date); SportDiscus (from in-
ception to date); and Ovid Embase (1988 to date). Medical
subject headings (MeSH) were exploded and combined
with relevant keywords that were truncated where re-
quired. The search was limited to adult human subjects
with no language restrictions applied. An example search
strategy for Ovid Medline is outlined (Additional file 1).
Further articles were sought from review of reference lists,
conference proceedings and personal communications
with content experts (Figure 1).
Two authors independently reviewed titles and ab-
stracts of all studies generated by the search strategy
using the inclusion and exclusion criteria. Consensus
was reached for included studies through discussion
with all three authors.
Eligibility criteria
Studies were included if:
1. The study was published in a peer-reviewed journal.
2. The study design was a randomised controlled trial
(RCT), controlled clinical trial (non-randomised
intervention trial with a separate control group) or
repeated measure intervention trial where
participants acted as their own control.
3. Participants were adults with flexible pes planus
defined using a reliable and validated foot morphology
or posture index (median of available published
reliability data of ICC ≥ 0.50) (Additional file 2).
4. The intervention was a rigid or semi-rigid FO where
the orthoses were required to meet the standards
defined by the Australian Podiatry Council for pre-
formed or pre-moulded, moulded non-cast, moulded
cast, or customised kinetic orthoses [35].
5. The comparison included a no-FO (shoes alone or
flat non-posted insert) condition.
6. Outcome measures included a measure of foot pain/
fatigue and/or functional changes in relation to:
rearfoot kinematics (excessive rearfoot eversion,
increased range or angular velocity of rearfoot
eversion); foot kinetics (reduction of force, rearfoot
joint moment or change in timing of force or
moment) or physical function (changes in energy
cost, lower limb muscle activation and timing, or
postural control) during weight bearing, bipedal
activities (standing, walking or running).
Studies were excluded if the participants had: a history of
significant trauma, disease, inflammatory or systemic con-
dition that may affect lower limb function (e.g. diabetes,
neurological dysfunction, rheumatoid arthritis); had previ-
ously worn orthoses in the past six months; or the risk of
bias of the study was deemed unacceptable (Figure 1).
Risk of bias assessment
Risk of bias was assessed using the McMaster critical re-
view form – Quantitative studies [36] and descriptive
guidelines [37] which is applicable to RCTs, controlled
clinical trials and repeated measure intervention trials.
The tool has fifteen individual assessment points within
eight domains. These are the study purpose, literature
review, sample (described, justified, reliable), outcomes
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(reliable, valid), intervention (described, not contaminated,
co-intervention/s avoided), results (statistically significant,
appropriate analyses, clinically important), drop outs and
conclusions (including clinical implications). The report-
ing of drop outs was not applicable for repeated measure
trials and therefore was excluded from the critical review.
Studies were awarded a ‘yes’ or ‘no’ rating for each individ-
ual assessment point of the remaining seven domains. A
‘yes’ rating was applied if the study completely fulfilled the
criterion and a ‘no’ rating if the criterion was not com-
pletely fulfilled. Domains were required to have a ‘yes’ rat-
ing for a minimum of 50% of the individual assessment
points to be considered acceptable. An a priori decision
was set to include only studies deemed acceptable in four
or more of the seven domains (Additional file 3). Risk of
bias assessment was completed by two reviewers inde-
pendently and discussions held until consensus.
The Australian National Health and Medical Research
Council’s (NHMRC) evidence hierarchy was used to deter-
mine the level of evidence for each study with systematic
reviews of RCTs considered high (level I) evidence, RCTs
good (level II) evidence, pseudo-RCTs (controlled clinical
trials) moderate (level III) evidence and repeated measure
trials low (level IV) evidence [38].
Data management
Data describing the sample characteristics, intervention
characteristics, study protocol and adverse effects were ex-
tracted by two reviewers independently, from all studies,
with consensus on results. Two reviewers independently
extracted data with consensus on results. Novel measures,
with no independent reliability or validity data, outcomes
that were repetitious (within the same study) and those
considered outside the scope of this review (extraneous)
were excluded by consensus of three reviewers (Additional
file 4). Means and standard deviations (SD) for each group
were extracted where data were provided or supplied on
request [34,39-44].
When more than one type or prescription approach of
FOs were investigated, each device within the study was
Records identified through database 
searching
(3166)
Additional records identified through
other sources
(10)










No control (shoe alone) condition (10)
Not reliable pes planus measure (3)
Not semi-rigid or rigid FO (6)
Orthoses previously worn (3)
Cohort not adult pes planus (10)
Outcome measures not relevant (2)







Figure 1 Flow chart of study selection.
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allocated simple identification (Device A, B etc.). Device
A from one study is not comparable with Device A from
an alternative study (Table 1).
Outcomes are reported for pain, rearfoot kinematics,
foot kinetics and physical function. All tabled data are
displayed in descending level of evidence, followed by
descending levels of assessed risk of bias concerns,
followed by alphabetical order unless otherwise noted.
Statistical methods
Sample size weighted standardised mean differences
(SMD) and 95% confidence interval (CI) were calculated
using Cochrane Review Manager (V.5) using the differ-
ence in mean scores between the FO and no-FO condi-
tion divided by the pooled standard deviation. Where
the mean and standard deviations were not available for
each condition, SMDs were calculated on mean differ-
ence divided by standard deviation of the mean differ-
ence, multiplied by the square root of two [45]. SMDs
were considered statistically significant if the CI did not
cross zero. Results are presented in forest plots where
negative numbers favour the FO over the no-FO condi-
tion. Interpretations of the strength of the SMDs statis-
tics were based on Cohen’s guidelines [46] with small
effect ≥ 0.2, medium effect ≥ 0.5 and large effect ≥ 0.8.
Statistically significant SMDs of less than 0.2 were con-
sidered very small.
Results
Study selection and design
Initial searches identified 2,211 studies. Two thousand,
one hundred and sixty three (2,163) were excluded based
on title and abstract. Forty eight studies were reviewed
in full for eligibility, of which 35 studies were excluded
based on inclusion and exclusion criteria (Figure 1) leav-
ing 13 included studies (Table 1). No studies were high
level of evidence, two studies were good level of evi-
dence (RCTs), one study was moderate level of evidence
(controlled clinical trial) and ten studies were low level
evidence (repeated measure intervention trials).
Risk of bias assessment
All studies had identified risk of bias (Additional file 3).
While all included studies clearly stated their study
purpose and the level of statistical significance, of the
13 included studies, only one justified the sample size
[41]. Four studies had potential bias of co-interventions
[41,42,47,48]. Individual studies had a risk of bias within
the literature review [34], sample description [43], out-
come measure reliability [39], outcome measure validity
[49], intervention description [39,42,50], intervention con-
tamination [39,51], appropriate analysis of results [39,50],
clinical importance of results [49] and overall conclusion
[34,39,49,51].
Participants
In total, 312 participants were included in the 13 studies
(Table 1). Most participants were young adults with 10 of
the 13 included studies using cohorts aged 40 years or
less. One study only recruited females [50]. Zammit and
Payne [42] and Johanson et al. [49] recruited participants
from clinical practice. Esterman and Pilotto [34] recruited
air force cadets during basic training. Zifchock and Davis
[38] and Mündermann et al. [44] both targeted recre-
ational runners. Johanson et al. [46] and Hurd et al. [48]
did not recruit from a specific population but required
their participants to have forefoot varus of at least eight or
five degrees respectively. The remaining studies did not
report recruiting from specific cohorts. All studies re-
cruited people with pes planus based on static foot pos-
ture. All studies involved 50 or less participants. Zifchock
and Davis [41] had both high and low arch participants
and did not report the low arch group separately. The au-
thors kindly supplied data to isolate the low arch cohort.
Types of foot orthoses
No two studies used the same FOs or approach to pre-
scription (Table 1). Eight of the 13 studies involved two
or more types of FOs with three of those comparing the
same orthoses with different levels of customisation
and/or posting (Table 1). Ten standardised the shell type
and the level of rearfoot and forefoot posting across the
cohort [34,39,40,43,44,47,48,50-52]. Two studies inde-
pendently prescribed post levels, based on foot morph-
ology, using different approaches [41,49]. One study
investigated a combination of customised and prefabri-
cated FOs individually prescribed [42] (Table 1).
Outcome measures
All of the included studies used different outcome mea-
sures and measurement approaches (Tables 2, 3, 4 and 5).
No study reported on adverse effects. The comparisons
(SMD) between FO and no FO conditions for all relevant
outcome measures are presented in Figures 2, 3, 4 and 5.
Pain
Two studies measured pain changes. One study (level II)
reported no significant change in pain [34] and the other
study (level IV) reported significant improvement in
pain scores with FO use [42] (Table 2). Esterman and
Pilotto [34] had a small, non-significant SMD for redu-
cing ‘lower limb pain in previous 24 hours’ when com-
paring their intervention and control groups over eight
weeks of basic training in air force recruits (Table 2).
Data from Zammit and Payne [42] indicated a large
SMD (mean difference of 21.02 points on the foot health
status questionnaire (FHSQ) in reducing foot pain fol-
lowing four weeks of FOs use within a clinical cohort
(Figure 2).
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FOs shell material FOs posting
RF FF
Rome and Brown [48] II RCT 50 (25/25) Excessive pronators 23.8 (2.2) FPI-8 Physical function Talar made © EVA 5° 0°
Esterman and Pilotto [34] II RCT 47 (25/22) Air force recruits 21.6 (3.9) AI Pain AOL® Plastic 4° 4°
Otman et al. [50] III-2 CCT 20 (20/20) Female adults 25.8 (1.3) Radiographs Physical function Arch supports Polypropylene 0° 0°
Zifchock and Davis [41] IV RM 19 Low arched
recreation
runners
23.6 (6.4) AHI Rearfoot kinematics A. Modified Root
device
Graphite 0 – 7° 0°
B. KLM® Graphite NR NR








C. Pre-made Insert EVA 6 mm 6 mm
Cobb et al. [52] IV RM 16 Low mobile arch
adults








Murley et al. [40] IV RM 30 Adults 21.8 (4.3) AI & NH Physical function A. Inverted (Blake)
device
Polypropylene 20 ° 0°
B. Formthotic ® Duel density
polyethylene foam
6 mm 0°
Redmond et al. [44] IV RM 22 Excessive pronators 24 RE Kinetics A. Modified Root
device
Polypropylene 6° 0°
B. Pre-made Insert Thin card with
EVA posts
6° 0°
Zammit and Payne [42] IV RM 22 Excessive RF
pronators (clinical
practice)





Murley and Bird [40] IV RM 17 Adults 23.0 (5.0) FPI-6 Physical function A. Inverted (Blake)
device







Hurd et al. [51] IV RM 15 Recreational
runners
34.0 (10.0) FF to RF Rearfoot kinematics
and kinetics
A. Flat foot Insert © Polyurethane with a
poron layer
0° 4°



















Table 1 Table of included studies; level of evidence, cohort characteristics and type of FOs used (Continued)
Johanson et al. [49] IV RM 22 Physical therapy
attendees (clinical
practice)







B. Orthofeet Biothotics© As above 80% of
FF post
0°
C. Orthofeet Biothotics© As above 0° Up to
7 mm
D. Orthofeet Biothotics© As above 0° 0°






RM – repeated measure. CCT – controlled clinical trial. AHI – arch height index, AI – arch index, FF to RF – forefoot to rearfoot relationship, NH – navicular height, FPI-8 – Foot Posture Index – 8- item version,
FPI-6 – Foot Posture Index – 6- item version, RE- rearfoot eversion. MASS – maximum subtalar supination position, NR – not reported, FF – forefoot, EVA -ethyl vinyl acetate.
Orthotic Labs: Formthotic (Foot Science International, Christchurch, New Zealand) Flatfoot insert, (Hickory Brands, Inc, Hickory, NC, USA), Sofsole, LLC, Durham, NC), KLM (KLM Orthotic Laboratories; Valencia, CA, USA),





















Five studies (level IV) analysed rearfoot kinematics during
walking or running [41,47,49,51,52] with two studies report-
ing significant changes in kinematics with FOs use (Table 3).
Rearfoot eversion changes (peak and mean rearfoot ever-
sion) were reported in four studies comparing eleven
different types of FOs [41,47,49,51]. Significant decreases
in rearfoot eversion were reported in two studies. Johanson
et al. [49], noted peak rearfoot eversion was statistically sig-
nificantly decreased (mean difference 2.15°) for device A
during treadmill walking, with device B, C and D showing
medium and small SMDs that were not statistically signifi-
cant (Figure 3). Mündermann et al. [47] reported measures
Table 3 Relevant outcome measures related to the domain of rearfoot kinematics (significant SMD results are bolded) -
walking unless otherwise noted




Zifchock and Davis [41] Over-ground walking (2.0 m/s) in low
arch cohort
Peak RF eversion (°) 4.31 (2.5) A 5.45 (5.1)
B 4.38 (2.2)
RF eversion excursion (°) 10.60 (2.8) A 9.47 (1.9)
B 9.68 (1.8)
Peak RF eversion velocity (°/s) 155.65 (46.9) A 141.50 (47.2)
B 144.78 (46.5)
Mündermann et al. [47] Over-ground running (4.0 ± 0.2 m/s) in
recreational runners with everted rearfoot.
Peak foot eversion (°) * 16.00 (2.3) A 16.90 (3.6)
B 16.60 (2.5)
C 13.70 (2.7)
Peak foot eversion velocity (°/s) * 464.70 (155.2) A 484.40 (141.1)
B 476.80 (145.0)
C 392.90 (135.0)
Cobb et al. [52] Over-ground walking (1.3 to 1.4 m/s) in
low arch cohort
RF eversion excursion (terminal stance (°) 0.85 (0.8) A 0.28 (0.5)
0.02 (0.4) B 0.18 (0.3)
Hurd et al. [51] Over-ground walking (1.2 m/s ± 5%) in
forefoot varus cohort
RF eversion (initial contact) (°) −1.60 (3.6) A −1.00 (3.1)
B −0.30 (4.0)
Peak RF eversion (loading) (°) −3.40 (3.7) A −2.80 (5.6)
B −2.70 (5.3)
Over-ground running (1.7 m/s ± 5%) in
forefoot varus cohort
RF eversion (initial contact) (°) * −3.30 (4.0) A −2.50 (5.0)
B −2.30 (4.5)
Peak RF eversion (loading) (°) * −5.60 (3.5) A −5.30 (10.5)
B −5.60 (11.1)
Johanson et al. [49] Treadmill walking (1.11 m/s) in forefoot
varus cohort




FO – foot orthoses, RF – rearfoot, FF – forefoot, *during running.
Table 2 Relevant outcome measures related to the domain of pain (significant SMD results are bolded)




Esterman and Pilotto [34] 10 week basic air force training recorded
at baseline and 8 weeks
VAS 0 – 10, pain previous 24 hours
following 8 weeks of FO use
1.14 (2.4) NA 0.68 (1.5)
Zammit and Payne [42] FHSQ reported at baseline and 4 weeks Increase in FHSQ pain subscale following
4 weeks of FO use (reduction in pain)
49.84 (24.8) NA 70.86 (19.5)
VAS – visual analogue scale, FO – foot orthoses, FHSQ – foot health status questionnaire, NA – not applicable.
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Table 4 Relevant outcome measures related to the domain of kinetics (force and joint moment change) (significant
SMD results are bolded) –during walking unless otherwise noted




Mündermann et al. [47] Over-ground running (4.0 ± 0.2 m/s) Vertical impact peak (N) 1499.10 (255.6) A 1352.30 (233.6)
B 1400.40 (242.5)
C 1519.40 (265.9)
Peak loading rate (N/s) 52.50 (11.1) A 42.0 (10.9)
B 44.8 (11.1)
C 53.5 (11.9)
Redmond et al. [44] Over-ground walking (self-selected speed) Peak force (heel) (N) 544.50 (104.3) A 501.90 (97.3)
B 543.80 (100.6)
Peak force (midfoot) (N) 195.30 (62.7) A 234.20 (58.8)
B 156.20 (73.9)
Peak force (lateral FF) (N) 426.90 (12.1) A 396.90 (110.3)
B 429.90 (122.0)
Peak force (medial FF) (N) 188.50 (62.9) A 173.20 (65.4)
B 190.00 (72.2)
Peak force (hallux) (N) 148.90 (63.1) A 161.40 (54.9)
B 159.90 (53.9)
Force-time integral (heel) (N/s) 1436.20 (462.2) A 1285.00 (385.3)
B 1488.90 (441.1)
Force-time integral (midfoot) (N/s) 527.70 (224.4) A 812.30 (267.0)
B 454.40 (253.5)
Force-time integral (lateral FF) (N/s) 1394.70 (575.1) A 1056.90 (436.3)
B 1317.00 (520.5)
Force-time integral (medial FF) (N/s) 468.50 (212.1) A 340.30 (175.9)
B 423.50 (202.5)
Force-time integral (hallux) (N/s) 294.90 (141.5) A 304.60 (155.7)
B 317.70 (145.3)
Mündermann et al. [47] Over-ground running (4.0 ± 0.2 m/s) Peak ankle inversion moment
(Nm.kg−1)
0.47 (0.1) A 0.40 (0.1)
B 0.43 (0.1)
C 0.38 (0.1)
Time of ankle inversion moment
(% of gait cycle)
41.00 (5.5) A 39.90 (6.5)
B 41.40 (6.7)
C 40.20 (5.5)
Hurd et al. [51] Over-ground walking (1.2 m/s ± 5%) Peak RF moment (Nm.kg−1) 0.78 (0.4) A 0.74 (0.5)
B 0.88 (0.3)
Mean RF moment (Nm.kg−1) 0.04 (0.4) A −0.18 (0.5)
B 0.19 (0.5)
Over-ground running (1.7 m/s ± 5%) Peak RF moment (Nm.kg−1) 1.75 (0.7) A 1.23 (0.6)
B 1.76 (0.7)
Mean RF moment (Nm.kg−1) 0.71 (1.0) A 0.09 (1.0)
B 0.92 (0.8)
FO – foot orthoses, DF – dorsiflexion, PF – plantarflexion, RF – rearfoot, NA – not applicable.
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Table 5 Relevant outcome measures related to changes in: physical function (significant SMD results are bolded) –
outcomes are measured during walking unless otherwise noted




Rome and Brown [48] Quiet standing Mean of the 300 balance points measured
over 30 seconds (%)
49.40*^ NA 46.10*^
Medial to lateral sway - rate of deviation
from the mean balance over 30 seconds (%)
1.90*^ NA 1.30*^
Anterior to posterior sway - rate of deviation
from the mean balance over 30 seconds (%)
4.60*^ NA 4.80*^
Otman et al. [50] Walking on treadmill at
1.34 m/s
Energy cost (ml/kg/min) 13.90* NA 12.76*
Murley et al. [40] Over-ground walking
(self-selected ± 5%)
TP EMG peak amplitude (initial contact
and loading)%
101.91 (33.9) A 89.51 (36.8)
B 82.48 (31.8)
TP EMG RMS amplitude (initial contact
and loading)%
101.94 (30.9) A 89.37 (33.6)
B 80.01 (25.7)
TP EMG peak amplitude (midstance, terminal
and pre-swing) (% of gait cycle)
90.96 (28.8) A 89.62 (22.2)
B 87.34 (27.3)
TP EMG RMS amplitude (midstance, terminal
and pre-swing)%
89.60 (24.1) A 86.92 (17.83)
B 85.84 (23.9)
PL EMG peak amplitude (initial contact
and loading)%
80.16 (35.6) A 84.70 (42.1)
B 90.48 (47.3)
PL EMG RMS amplitude (initial contact
and loading)%
79.44 (27.6) A 84.25 (37.5)
B 98.10 (44.6)
PL EMG peak amplitude (midstance, terminal
and pre-swing) (% of gait cycle)
62.71 (32.6) A 67.78 (33.9)
B 83.76 (41.9)
PL EMG RMS amplitude (midstance, terminal
and pre-swing)%
71.90 (39.9) A 79.86 (46.0)
B 96.07 (47.9)
TA EMG peak amplitude (initial contact
and loading)%
116.32 (15.8) A 113.49 (15.3)
B 111.50 (17.4)
TA EMG RMS amplitude (initial contact
and loading)%
122.02 (19.8) A 119.79 (22.0)
B 113.00 (22.3)
TP EMG time of peak amplitude (initial
contact and loading) (% of gait cycle)
10.94 (1.7) A 11.37 (2.1)
B 11.10 (2.2)
TP EMG time of peak amplitude (midstance,
terminal and pre-swing) (% of gait cycle)
44.95 (4.3) A 44.92 (3.69)
B 45.55 (4.1)
PL EMG time of peak amplitude (initial
contact and loading) (% of gait cycle)
10.65 (3.4) A 10.52 (3.5)
B 10.23 (4.6)
PL EMG time of peak amplitude (midstance,
terminal and pre-swing) (% of gait cycle)
51.65 (7.0) A 50.55 (7.91)
B 50.26 (7.61)
TA EMG time of peak amplitude (initial
contact and loading) (% of gait cycle)
6.63 (1.4) A 6.28 (1.3)
B 6.39 (1.4)
Zammit and Payne [42] FHSQ reported at baseline
and 4 weeks
Increase in FHSQ function subscale
(increase in function)
64.94 (24.0)* NA 85.32 (17.7)*
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based on the foot modelled as a single rigid segment during
overground running. Within this study, device C reduced
foot eversion with a large SMD observed (mean difference
2.30°) in a cohort of recreational runners (Figure 3).
Two other studies investigated rearfoot eversion with
non-significant results. Zifchock and Davis [41] during
walking trials and Hurd et al. [51], during walking and
running trials (Figure 3).
Rearfoot eversion excursions were reported in three
studies [41,49,52] (Table 3). Zifchock and Davis [41] ob-
served non-significant SMDs for both device A and B to
reduce rearfoot eversion excursion (Figure 3). Cobb et al.
[52] reported non-significant SMDs for rearfoot eversion
excursion changes during terminal stance for both device
A and B (Figure 3). Johanson et al. [49] reported no change
to rearfoot excursion across all four FOs employed; how-
ever, data were not available to calculate SMDs.
Rearfoot eversion velocity was reported in two studies
comparing five FOs (Table 3). Zifchock and Davis [41] ob-
served non-significant SMD decreases during overground
walking for device A and B (Figure 3). Mündermann et al.
[47], during overground running, observed non-significant
increases for device A and B, with a non-significant de-
crease observed with device C (Figure 3).
Kinetics
Kinetics of the foot were reported in four (level IV) studies
[39,44,47,51] investigating change in loading forces and
joint moments. Three of these studies reported at least
one statistically significant change with FO use (Table 4).
Changes in force and its derivatives across the foot
were reported in two studies [44,47]. Mündermann et al.
[47] reported no significant change in vertical impact
forces with all three devices (Figure 4). Peak loading
rates were significantly altered for two of the three FOs
used during overground running (Figure 4). A large
SMD, which represented a reduction in loading rate, was
observed with device A (mean difference 146.8 N/s). A
medium SMD, which also represented a reduction, was
observed with device B (mean difference 98.7 N/s). De-
vice C had no effect (Figure 4). Mündermann et al. [47]
also reported peak vertical ground reaction forces with
similar results (Additional file 4). When using plantar
pressure instrumentation, Redmond et al. [44] reported
Table 5 Relevant outcome measures related to changes in: physical function (significant SMD results are bolded) –
outcomes are measured during walking unless otherwise noted (Continued)
Murley and Bird [40] Over-ground walking
(self-selected speed)
PL EMG amplitude (% MVIC) 88.00 (26.5) A 98.00 (32.9)
B 107.00 (35.8)
C 99.00 (32.6)
TA EMG amplitude (% MVIC) 122.00 (38.4) A 123.00 (42.2)
B 129.00 (43.1)
C 125.00 (30.0)
Soleus EMG amplitude (% MVIC) 256.60 (89.6) A 251.93 (95.7)
B 255.70 (94.5)
C 260.92 (98.4)
Chen et al. [39] Over-ground walking
(1.09 ± 0.11 m/s)
Velocity (cm/s) 108.57 (11.3) NA 109.39 (11.1)
Cadence (steps/min) 103.98 (6.8) NA 104.73 (5.8)
Step width(cm) 15.44 (5.2) NA 15.44 (5.0)
Step length(cm) 63.09 (4.9) NA 61.81 (4.4)
Stance time (%) 63.72 (1.7) NA 63.93 (1.9)
FO – foot orthoses, EMG – electromyography, TP – tibialis posterior, PL – peroneus longus, TA – tibialis anterior, RMS – root mean square, MVIC – maximum
voluntary isometric contraction, FHSQ – foot health status questionnaire, NA – not applicable, N/A – not available, *No FO condition was prior to orthoses
dispense, the FO condition was following four weeks of orthoses use, ^ Median results and significance tabled as per original article– means and standard
deviations unavailable.
Figure 2 Forest plot of data pooling for the use of FOs for the domain of pain. FHSQ – foot health status questionnaire.
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a significant, medium SMD, increase in peak force across
the midfoot (mean difference 38.9 N) using device A
(Figure 4). No significant results were reported across
the heel, lateral and medial forefoot or hallux with device
A during overground walking (Table 4). No significant
changes across all foot regions were reported using device
B (Table 4).
Force-time integrals from plantar pressure instrumen-
tation were reported in one study comparing two FOs
[44] (Table 4). Device A had a statistically significant
large SMD effect in increasing the force-time integral
across the midfoot (mean difference 284.6 N.s) and
medium SMD reduction in the force-time integral at the
forefoot (medial and lateral) (mean difference 128.2 and
337.7 N.s respectively)(Figure 4). Device B had no sig-
nificant effects (Table 4). This study also reported mean
force, peak pressures, mean peak pressures and pres-
sure–time integrals (Additional file 4).
Changes in rearfoot joint moments were reported on in
two studies [47,51] (Table 4). Mündermann et al. [47] re-
ported reductions in peak ankle inversion moments during
running for all three devices; however, only the medium
SMD reduction effect observed for device C (mean differ-
ence 0.09 Nm.kg−1) was statistically significant (Figure 4).
No significant differences were observed for the timing of
the moment within the same study (Table 4). Hurd et al.
[51], reported a significant reduction in peak rearfoot ever-
sion moments during running with device A (mean differ-
ence 0.62 Nm.kg−1) of a large SMD; whereas device B
had no significant effect (Figure 4). The same protocol,
during walking, produced no significant differences using
either FOs. Mean rearfoot eversion moments were altered
with device A, with (non-significant) a small SMD reduc-
tion during walking (mean difference 0.53 Nm.kg−1) and
(non-significant) a medium SMD reduction during running
observed (mean difference 1.34 Nm.kg−1) (Figure 4).
Figure 3 Forest plot for data pooling for the domain of rearfoot kinematics. RF – rearfoot, ever – eversion, ft – foot, excur – excursion, vel –
velocity, *observed during running.
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Conversely, using device B, small SMD increases were
noted for both walking and running that were not statisti-
cally significant (Figure 4).
Physical function
Six studies reported on physical function changes. Out-
come measures included postural sway [48], energy ex-
penditure [50], electromyography (EMG) [40,43], FHSQ
[42] and spatiotemporal gait variables [39]. One was
level II [48], one was level III [50] and five were level IV
[39,40,42,43]. Four of these studies reported significant
changes in at least one outcome with FOs use (Table 5).
Postural sway in quiet standing was reported in Rome
and Brown [48] in a RCT comparing FOs to shoes alone
in two separate groups. Both groups were assessed in
a shoes alone condition (session one) and again four
Figure 4 Forest plot of data pooling for the domain of kinetics. Pk – peak, FF – forefoot, lat – lateral, med – medial, vert – vertical, F-t integ –
force time integral, RF – rearfoot, mo – moment, inv – inversion, *observed during running.
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Figure 5 Forest plot of data pooling for the domain of physical function. EMG – electromyography, TP – tibialis posterior, RMS – root mean
square, PL – peroneus longus, TA – tibialis anterior, MVIC – maximum voluntary isometric contraction, amp – amplitude, (1) – initial contact and
loading, (M) – midstance, terminal and pre-swing.
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Table 6 Outcomes and device review categories of FOs where statistically significant SMDs were observed^ (in descending effect size) (during walking unless
otherwise noted)
Study Level of evidence SMD 95% CI Domain Specific outcome Device Difference
in mean
Otman et al. [50] III −4.11 −5.24 to −2.98 Physical function ↓ energy cost at 1.34 m/s, 0 incline (ml.kg.min-1) NA 1.14
Redmond et al. [44] IV 1.13 0.49 to 1.77 Kinetics ↑ force-time integral (midfoot) (N/s) A 284.60
Mündermann et al. [47] IV −0.94* −1.58 to −0.30 Kinetics ↓ peak loading rate (N/s)* A 10.50
Zammit and Payne [42] IV −0.93 −1.55 to −0.30 Pain ↓ FHSQ pain subscale following 4 weeks of use (%) NA 21.00
Mündermann et al. [47] IV −0.90* −1.54 to −0.26 Rearfoot kinematics ↓ peak foot eversion (°) * C 2.30
Hurd et al. [51] IV −0.78* −1.52 to −0.03 Kinetics ↓ peak RF eversion moments (Nm.kg-1) * A 0.52
Mündermann et al. [47] IV −0.75 −1.38 to −0.13 Kinetics ↓ peak ankle inversion moment (Nm)* C 6.00
Murley et al. [40] IV −0.76 −1.29 to −0.24 Physical function ↓ TP EMG RMS amplitude (initial) (%) B 21.93
Zammit and Payne [42] IV −0.76 −1.37 to −0.14 Physical function ↓ FHSQ function subscale following
4 weeks of use (%)
NA 20.40
Johanson et al. [49] IV −0.72 −1.33 to −0.11 Rearfoot kinematics ↓ peak RF eversion (°) A 2.15
Mündermann et al. [47] IV −0.68 −1.30 to −0.06 Kinetics ↓ peak loading rate (N/s)* B 7.70
Redmond et al. [44] IV −0.65 −1.26 to −0.04 Kinetics ↓ force-time integral (lateral FF) (N/s) A 337.80
−0.65 −1.25 to −0.04 Kinetics ↓ force-time integral (medial FF) (N/s) A 128.20
0.63 0.02 to 1.24 Kinetics ↑ force at midfoot (N) A 38.90
Murley et al. [40] IV −0.58 −1.10 to −0.07 Physical function ↓ TP EMG peak amplitude (initial) (%) B 19.43
Murley et al. [40] IV −0.55 −1.07 to −0.04 Physical function ↑ PL EMG peak amplitude (midstance +) (%) B 21.05
Murley et al. [40] IV −0.54 −1.06 to −0.03 Physical function ↑ PL EMG RMS amplitude (midstance +) (%) B 18.66
SMD values to the negative favour the FO condition over the no-FO condition.
FO – foot orthoses, RF – rearfoot, EMG – electromyography, TP – tibialis posterior, PL – peroneus longus, RMS – root mean square, FHSQ – foot health status questionnaire, NA – not applicable, *outcomes observed



















weeks later (session two) where the intervention group
were tested in FOs. A significant reduction in medial-
lateral sway (32% improvement) was reported in the FOs
group; however, data were not available to calculate
SMDs (Table 5).
Energy expenditure changes were reported in a con-
trolled clinical trial [50], with a large SMD observed within
the pes planus group (Figure 5) indicating significant de-
creases in total energy cost during treadmill walking (mean
difference 1.14 ml.kg.min−1) in comparison to the no-FO
condition (Table 5). The non-pes planus (control) group
remained consistent over the two testing sessions. This
study also reported large energy expenditure savings dur-
ing walking on inclines and positive effects for oxygen con-
sumption for the pes planus group when using FOs during
the same testing sessions (Additional file 4).
Changes in EMG of lower limb muscles during over-
ground walking were reported in two studies, one measur-
ing muscle activation and timing for two different FOs
[40] and one measuring activation only for three different
FOs [43] (Table 5). Murley et al. [40] reported a reduced
tibialis posterior peak and root mean square (RMS) EMG
amplitude at initial contact and loading (mean difference
19.4 and 21.9% respectively) with device B. Both these out-
comes were calculated as a statistically significant medium
SMD reduction in EMG amplitude (Figure 5). This was in
conjunction with an increased peroneus longus peak and
RMS EMG amplitude during midstance, terminal stance
and pre-swing (mean difference 21.0 and 24.2% respect-
ively) and RMS EMG amplitude during initial contact and
loading (mean difference 18.6%) when using the same
FOs (Table 5). These results were not reported with device
A, nor were any other statistically significant SMDs re-
ported using device A or B for tibialis anterior (Figure 5).
This study also reviewed both devices influence on medial
gastrocnemius (Additional file 4). In another EMG study
[43], no statistically significant SMDs were observed for
changes in amplitude of tibialis anterior, peroneus longus
or soleus using three FOs with different posting levels
(Figure 5).
Increases in self-reported function were reported
(mean change 20.38 points on the FHSQ function sub-
scale) (Table 5). A statistically significant medium SMD
improvement was observed following four weeks of use
of individually prescribed FOs in a cohort recruited from
clinical practice [42] (Figure 5). Another study investi-
gated gait velocity, step length and cadence and reported
non-significant changes with FO use [39] (Table 5). This
study also investigated stride length, reporting no effect
(Additional file 4).
Summary of results
From the 13 studies included, data were extracted for
59 relevant outcome measures related to the signs
(rearfoot kinematics, foot kinetics and physical function)
and symptoms (pain) associated with flexible pes planus
(Tables 2, 3, 4 and 5). From these 59 outcome measures,
41 results reported across 13 studies were not statistically
significant. Of the 13 studies reporting non-significant re-
sults, one was a level 11 [34] and 11 were level IV evi-
dence [39-44,47-49,51,52]. Eighteen outcomes reported
across eight studies were statistically significant (Table 6).
Of the eight studies reporting statistically significant re-
sults, one was level 11 [48], one was level III [50] and six
were level IV evidence [40,42,44,47,49,51]. Available data
demonstrated that all statistically significant outcomes
were a large or medium SMD effect when comparing the
FO to the no FO condition (Table 6).
The largest SMD (−4.11, CI −5.24 to −2.98) was ob-
served in the domain of physical function (Table 6) in
Otman et al.’s [50] controlled clinical trial that investigated
changes in energy cost during treadmill walking, in a fe-
male pes planus group, with and without FOs (Table 6).
These results favour the FO condition (Figure 5). The next
largest SMD (1.13, CI 0.49 to 1.77) was within the domain
of kinetics where Redmond et al. [44] investigated changes
in the force-time integral at the midfoot (Table 6). This re-
sult favoured the no FO condition (Figure 4). This was the
only statistically significant SMD effect that favoured the
no FO condition (Table 6). Large effects within individual
studies were also observed for reducing peak loading rates,
pain and peak foot eversion (Table 6).
Discussion
The aim of this systematic review was to assess the ef-
fectiveness of FOs to alter signs (abnormal rearfoot kine-
matics, abnormal kinetics and altered physical function)
and symptoms (pain and fatigue) associated with flexible
pes planus in adults. Key outcomes of this systematic re-
view are that there are only two RCTs investigating the
use of FOs for adults with flexible pes planus and that
all studies had identified risk of bias issues (Additional
file 3) and concerns regarding participant recruitment,
choice of FOs or the outcome measures.
Pes planus and participant recruitment
Each study used a different measure of pes planus and
there was no consistency in recruitment criteria among
studies. The majority of studies recruited cohorts of con-
venience based on static pes planus measures. It would
seem more appropriate to investigate effectiveness of an
intervention within a participant group who have recog-
nised symptoms associated with the condition. One of
the two studies that recruited from clinical practice re-
ported large and medium SMD effects on pain and self-
reported function [42] (Figures 2 and 5). These out-
comes could, arguably, be the most clinically important
measures included within this review.
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Approach to FOs
Concerns around the type of FOs employed were noted.
The type of FOs selected for investigation in a study was
rarely justified and often not described in detail. Ten of the
included studies standardised the shell and approach to
posting [34,39,40,43,44,47,48,50-52], only three studies indi-
vidualised their approach [41,42,49]. A criticism of FOs
intervention studies, anecdotally at least, is the justification
of the FOs used and the apparent ad hoc approach to pre-
scription options. This may be related to an absence of ap-
propriate prescription guidelines to direct the researcher
[53]. Currently there is no evidence to suggest that individu-
ally prescribing FOs offers any benefits over standardised
devices, however if the FOs investigated in research are not
mirroring those used in clinical practice then the evidence
may also not be easily translated to clinical situations. The
effect of the diversity of FOs used in the studies on the over-
all results of this review is unknown, and requires a further
review with separate analyses. Further research into the im-
pact of different approaches to the FOs used across all foot
types is recommended along with the development of ap-
propriate prescription guidelines to ensure future research
outcomes are a genuine reflection of clinical practice results.
Choice of outcome measures
The symptom of fatigue was not measured in any study
and changes in pain levels were only investigated in two
studies. This was surprising given that pain and fatigue are
assumed to be common drivers for people with flexible
pes planus to seek podiatric intervention [1,22,54]. Within
this review, pain was significantly reduced when FOs were
independently prescribed within a clinical cohort (Table 2);
however, with no separate control group (or ‘sham device’
group) improvements in pain levels cannot be attributed
to the FOs alone and may simply reflect pain resolving
over time, a placebo or a Hawthorne effect [46].
Changes in rearfoot kinematics were frequently investi-
gated (Table 3). Changes were noted predominantly in
rearfoot eversion during walking with the measured re-
duction being significant (Figure 3). It is important to note
that the actual magnitude of change is small (1.28 to 2.30°)
and falls within accepted levels of measurement error [55].
It has also been suggested that this magnitude of effect on
rearfoot kinematics is clinically meaningless and a direct
link between rearfoot positioning and functioning has yet
to be established [56]. Overall, the majority of rearfoot
kinematic measures were not significant (Table 3).
Within the domain of kinetics, only two reported out-
come measures demonstrated a statistically significant
reduction for loading forces, both observed during run-
ning trials (Figure 4). Loading forces during walking
were increased across the midfoot with the use of FOs
and there was not a lateral shift of force demonstrated
as expected (Figure 4). Results may have been influenced
by both the use of an in shoe insole placed over the top
of the orthoses and by the methods adopted for the
quantitative analysis within this domain. The assumption
was made that the goal of FO therapy was to reduce the
overall force and decrease the time the force was applied
[25]. Therefore, the increase in the amount and time of
force measured across the midfoot was allocated as
favouring the no FO condition (Figure 4). In essence, the
actual clinical consequences of the changes in measured
force and timing reported is not clearly understood [44]
and interpretation of results should be viewed accordingly.
The impact on physical function is where the highest
level of evidence was found (Table 5). Both medial-
lateral sway during quiet standing and energy cost were
positively affected with the use of FOs and offer good
and moderate levels of evidence. This supports the his-
torical belief that people with pes planus had reduced ef-
ficiency in gait, a belief that restricted entry into military
service in the Australian, British and US armed forces
for both World Wars [2]. Interestingly, while the use of
FOs for improved stability in stance is supported within
the literature [57,58], energy cost studies using FOs in
other populations do not concur with the outcomes re-
ported within this review. Hennacy [59] concluded that
FOs, within a ‘foot problem’ group, induced an initial in-
crease in energy consumption that returned to normal
within three months. In a more recent study, Kelly [54]
reported that no statistically significant changes were
noted in energy cost during, and following, a one hour
run with and without FOs in a non-pes planus cohort.
Based on the outcomes of this systematic review, further
investigations of energy cost and postural control within
a flexible pes planus adult population is warranted.
Limitations
Only a small number of studies were included in this re-
view. All of the included studies had identified risk of bias
with the assessment of risk of bias undertaken with a tool
that allocated equal weight to all criteria (Additional file
3). Ten of the included studies are low level evidence
(level IV) (Table 1) with all 10 being a repeated measure
study design and eight of the 10 studies investigating two
or more types of FOs. These studies met the required in-
clusion criteria; however, their inclusion may have affected
the conclusions. To manage data levels and reduce errors
from the same participants appearing repeatedly in ana-
lyses, several outcome measures were excluded on the
basis they were considered repetitious or extraneous
(Additional file 4), the effect of excluding these data on
the results reported remain unknown.
Conclusion
Within the limits of this systematic review it was deter-
mined that low level evidence exists that FOs positively
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impact on rearfoot kinematics, kinetics and physical func-
tion in adults with flexible pes planus. The small number
of studies included and the risk of bias within the studies
mean the clinical implications of the results of this review
are not known. There is little evidence that FOs reduce
pain and no evidence that FOs reduce fatigue.
Without high level evidence to support the purported
effects of FOs podiatric clinicians are faced with the quan-
dary of working within the bounds of evidence based prac-
tice, balanced against potentially conflicting clinical
experience. Foot orthoses, specifically Root and modified
Root devices, have been used for over 40 years with ‘arch
inserts’ pre-dating them by over a century [18]. This re-
view indicates that there are measurable consequences to
FO use for the flexible pes planus in adults but these im-
pacts are minimal. Quality research with clinically relevant
outcomes, based on protocols that mirror clinical practice
is required. This will allow future research to direct the
development of robust and effective intervention pathways
that offer the best possible outcome to the flexible pes pla-
nus adult population.
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are bolded).
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